LifeArc | Drug repurposing to treat chronic respiratory infection
Event details
| Date | 15.01.2025 |
| Category | Call for proposal |
Aim: People with bronchiectasis, cystic fibrosis and other chronic respiratory conditions require treatments that address the vicious cycle of infection, inflammation and lung damage. Approaches involving repurposing and reformulation of existing drugs are potentially a more rapid way to bring treatments to patients.
Funding will support drug repurposing projects that seek to conduct translational studies, from proof of concept and preclinical studies through to clinical studies, in order to progress existing drugs through the development path towards patients. It is anticipated that funded projects would be 2-3 years in length. Drug repurposing projects should have the potential to move treatments quickly to patients.
Funding: up to £1M
Duration: up to 3 years
Eligibility: The opportunity is open to academic, SMEs and government-based organisations based in the UK or abroad. The principal investigator should have demonstrable experience in leading multi-investigator and multidisciplinary consortia or, at a minimum, applicants should demonstrate their potential to lead and manage a large-scale collaborative project.
How to Apply: Expression of Interest should be submitted through the foundation’s online portal. If the project is within remit, applicants may be invited to an online discussion with the foundations’ partnership team. This online call will allow the partnership team to better understand the project and whether it is likely to be within remit. In this discussion, the partnership team may be able to offer further advice and shaping of project proposed in the EOI.
Deadline: 15 January 2025
Further information
Funding will support drug repurposing projects that seek to conduct translational studies, from proof of concept and preclinical studies through to clinical studies, in order to progress existing drugs through the development path towards patients. It is anticipated that funded projects would be 2-3 years in length. Drug repurposing projects should have the potential to move treatments quickly to patients.
Funding: up to £1M
Duration: up to 3 years
Eligibility: The opportunity is open to academic, SMEs and government-based organisations based in the UK or abroad. The principal investigator should have demonstrable experience in leading multi-investigator and multidisciplinary consortia or, at a minimum, applicants should demonstrate their potential to lead and manage a large-scale collaborative project.
How to Apply: Expression of Interest should be submitted through the foundation’s online portal. If the project is within remit, applicants may be invited to an online discussion with the foundations’ partnership team. This online call will allow the partnership team to better understand the project and whether it is likely to be within remit. In this discussion, the partnership team may be able to offer further advice and shaping of project proposed in the EOI.
Deadline: 15 January 2025
Further information
- More information about the program is available here
- The application portal can be found here
- For any other questions, please contact the Research Office
Practical information
- General public
- Free